RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023

Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST) announced it will release its fourth quarter and fiscal year 2022 financial results on March 6, 2023, following market close. Management will hold a conference call at 1:30 p.m. PT to discuss the results. Interested participants can register for the call and access the live webcast on the company’s investor relations page.

RxSight specializes in ophthalmic medical devices and offers the innovative RxSight Light Adjustable Lens system, the first adjustable intraocular lens technology, enhancing patient vision post cataract surgery.

Positive

• Announcement of Q4 and FY 2022 financial results reporting, a key event for investors.
• The RxSight Light Adjustable Lens system represents a unique and innovative product in cataract surgery.

Negative

• None.

ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth quarter and fiscal year 2022 after the market close on Monday, March 6, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Participants may register for the call here and listen through a live and archived webcast of the event available for one year at https://investors.rxsight.com/. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option).

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high quality of vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
ir@rxsight.com

FAQ

When will RxSight report its fourth quarter and fiscal year 2022 financial results?

RxSight will report its financial results on March 6, 2023.

What time is the RxSight conference call to discuss financial results?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I listen to the RxSight financial results conference call?

Participants can register for the call and listen via a live and archived webcast on the RxSight investor relations page.

What is the RxSight Light Adjustable Lens system?

It is the first adjustable intraocular lens technology that allows doctors to customize a patient's vision post cataract surgery.

What is the stock symbol for RxSight?

The stock symbol for RxSight is RXST.